← Leaderboards
Jon Miralis
Sri International
$177,346
Attributed
$177,346
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $137.3K · FY2021–22$200K$150K$100K$50K$0
'21
'22
Funding mix
By agency
NIH$177,346 · 1
By mechanism
N01$177,346 · 1
Top collaborators
No co-investigators on record.
Most similar at Sri International
Same institution · by research overlap
- Polly Chang$121,906,628
- Kathryn Baughman$29,412,662
- Carol E Green$19,982,282
- Jon Mirsalis$56,020,705
- Hanna Ng$10,741,273
Others in their field
Other Emerging Leaders on “Acquired Immunodeficiency Syndrome”
- Kimberly Smith · Ppd Development Lp$122,008,792
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,132,816
- Bambra Strokes · Ppd Development Lp$65,000,267
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
Research focus
Acquired Immunodeficiency SyndromeClinical InvestigationCo-InfectionContractsDevelopment PlansDrug DevelopmentFormulationHiv InfectionsHiv TherapyMicrobicideNational Institute Of Allergy And Infectious DiseasePharmacologic SubstancePharmacology And ToxicologyPreventResearch PersonnelServicesSexual Hiv TransmissionTherapeutic AgentsTransmission ProcessUnited States Dept. Of Health And Human ServicesUnited States National Institutes Of HealthQuality ControlBaseReporting
Grant awards (3)
Preclinical Development Services for AIDS Therapeutics$40,047
N01 · FY2022 · AI · contact PI
Preclinical Development Services for AIDS Therapeutics$102,771
N01 · FY2021 · AI · contact PI
Addition of Final Bioanalytical Long-Term Stability Time Points for GLP Studies of TLC-ART 101 in Rats and Dogs$34,528
N01 · FY2021 · AI · contact PI